Survodutide
A glucagon/GLP-1 dual agonist studied in weight and liver research.
Get told when a price moves or a lab test changes.
Observed median price
$130
Every observation
| Date | Observed |
|---|---|
| $104.00 | |
| $132.80 | |
| $129.99 | |
| $104.00 | |
| $129.99 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 | |
| $78.00 | |
| $78.00 | |
| $78.00 | |
| $129.99 |
Median of 3 listings' 30-day changes; 1 excluded for insufficient history.
4
Active listings
0
Independent lab tests
$78–$200
Observed price range
3
Known aliases
Understand this compound
What is Survodutide?
In clinical trialsA weight-loss molecule that pairs appetite suppression with a signal telling the liver to burn fat. In late-stage trials for obesity and fatty liver disease.
Good to know: GI side effects are common in trials, and as an unapproved investigational drug there is no verified manufacturing standard outside trial supply.
How does Survodutide work?
The science
A dual GLP-1/glucagon receptor agonist; combines appetite suppression and satiety signaling with glucagon-receptor-mediated increases in hepatic fat oxidation and energy expenditure.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
What is Survodutide researched for?
Studied for obesity and for metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH).
- Weight & metabolicStudied in weight, appetite, blood-sugar, and fat-metabolism research.
How far has the research gone?
In clinical trials; Phase 3 (SYNCHRONIZE program) reporting positive weight-loss and liver-fat data, not yet FDA-approved.
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
What should I check before buying?
- Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
- Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
- Vendor reputation. See how the vendor is talked about in the community before trusting a new name.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
Current market
The Survodutide market
Every Survodutide listing we track — 4 in all. The standout picks first where the evidence supports them, then the full table, ranked by what a milligram really costs wherever the vendor published a strength we can read.
Open full marketSurvodutide 10mg
EZ PeptidesA
$78$7.80/mg-22% vs median
Lowest price per mg that isn't flagged as suspiciously cheap.
In stockChecked 11 hours ago
SURVODUTIDE PEPTIDE 10MG/20MG VIAL 20 Milligrams Vial
Umbrella LabsC-
$200$10.00/mg
The most recently re-verified listing on this market.
In stockChecked 11 hours ago
SURVODUTIDE PEPTIDE 10MG/20MG VIAL
Umbrella LabsC-
$130$13.0/mg+30% vs median
Ranked #3 of 3 listings by price per milligram.
In stockChecked 11 hours ago
Compare by real cost
Every Survodutide listing, cheapest per mg first
Sticker prices hide the size, so listings are ranked by what a milligram actually costs — with independently tested purity where it exists. All 4 are here: the last 1 is a listing whose vendor never published a strength we can read, so it has no per-mg figure to sort on.
| # | Vendor | Size | Price | Per mg | Tested purity | Real $/active mg | |
|---|---|---|---|---|---|---|---|
| 1 | Ez Peptides | 10mg total | $78 | $7.80/mg | — | — | View |
| 2 | Umbrella Labs | 20mg total20 Milligrams Vial each | $200 | $10.00/mg | — | — | View |
| 3 | Umbrella Labs | 10mg total | $130 | $13.0/mg | — | — | View |
| Listed, but not rankable — no published strength to price per mg | |||||||
| — | PurerawzUnavailable | 1 vial | $133 | no size published | — | — | View |
Open the full Survodutide market
Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg. A vendor shown as Unavailable or Low stock is priced here but not currently buyable.
What the research says
Scientific evidence & regulatory status
What the published literature actually shows about Survodutide — separate from any vendor’s marketing. Each finding links to its paper. This is education, not medical or dosing advice.
Regulatory status
No FDA-approved drug
Not FDA-approved; an investigational dual glucagon/GLP-1 receptor agonist in Phase 3 trials for obesity and metabolic liver disease, with no marketing authorization identified anywhere.
Investigational drug — not approved, under FDA scrutiny
This is an investigational dual-agonist still in trials. It has no FDA approval for any use, is not a supplement, and the FDA is actively watching the GLP-1-class “research” market. Sold research-use-only; marketing or using it as a drug is not lawful.
General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Research notes aren’t product proof
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.